| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5852922 | Food and Chemical Toxicology | 2012 | 8 Pages |
Abstract
⺠120 randomized subjects received microencapsulated Lactobacillus reuteri NCIMB 30242 yogurt or placebo yogurt twice daily for 6 weeks. ⺠No clinically significant differences between groups were detected in blood clinical chemistry or hematology. ⺠Analysis of fecal samples indicated that there was no significant increase in fecal deconjugated bile acids. ⺠The frequency and intensity of adverse events was similar in the two groups.
Keywords
PO43−CSVBSHQPSALKPALTGGTSOPCa2+Cl−Na+LABASTAspartate aminotransferasealanine transaminaseAlkaline phosphataseSafetyLactic acid bacteriabpmANOVAone-way analysis of variancenumber of subjectsStandard operating proceduresSodiumbody mass indexBMIbeats per minuteAdverse eventsPhosphateLactobacillusMicroencapsulationpatient-reported outcomePROBile salt hydrolasePotassiumProbioticqualified presumption of safetyAPAChlorideCalciumquality controlgamma-glutamyl transpeptidase
Related Topics
Life Sciences
Agricultural and Biological Sciences
Food Science
Authors
Mitchell L. Jones, Christopher J. Martoni, Sandeep Tamber, Mathieu Parent, Satya Prakash,